Research Chair in Chemosensory Neuroanatomy, Department of Anatomy, Université du Québec à Trois-Rivières (UQTR), Trois-Rivières, QC, Canada.
Department of Otorhinolaryngology, Smell and Taste Clinic, Technical University of Dresden, Dresden, Germany.
J Neurol. 2019 Dec;266(12):2942-2951. doi: 10.1007/s00415-019-09517-4. Epub 2019 Aug 26.
Olfactory dysfunction is a frequent early non-motor symptom of Parkinson's disease (PD). There is evidence that with regard to trigeminal perception, PD-related olfactory dysfunction is different from other olfactory disorders. More specifically, trigeminal sensitivity, when measured behaviorally, was unimpaired in PD patients as opposed to patients with non-Parkinsonian olfactory dysfunction (NPOD). We sought to investigate the trigeminal pathway by measuring electrophysiological recordings from the nasal epithelium and EEG-derived event-related potentials in response to a specific trigeminal stimulus in 21 PD patients and compare them to 23 patients with NPOD and 25 controls (C). The peripheral trigeminal response, as measured by the negative-mucosa potential, showed no difference between patients with PD and controls whereas PD patients showed faster responses than patients with NPOD, the latter having shown slower and larger responses than controls (18 PD, 14 NPOD, 20 C). The central trigeminal response, as measured by event-related potentials, revealed larger early component response in PD patients compared to patients with NPOD (15 PD, 21 NPOD, 23 C). As expected, psychophysical olfactory testing showed impaired olfactory function in both groups of patients as opposed to controls. Discriminant analysis revealed a model that could predict group membership for 80% of participants based on the negative-mucosa potential latency, olfactory threshold and discrimination tests. These results provide novel insights into the pattern of trigeminal activation in PD which will help to differentiate PD-related olfactory loss from NPOD, a crucial step towards establishing early screening batteries for PD including smell tests.
嗅觉功能障碍是帕金森病(PD)常见的早期非运动症状。有证据表明,就三叉神经感知而言,与 PD 相关的嗅觉功能障碍与其他嗅觉障碍不同。更具体地说,与非帕金森嗅觉障碍(NPOD)患者相比,PD 患者的三叉神经敏感性在行为测量时并未受损。我们试图通过测量 21 名 PD 患者和 23 名 NPOD 患者以及 25 名对照(C)的鼻腔上皮细胞的电生理记录和脑电图衍生的事件相关电位来研究三叉神经通路。作为衡量三叉神经外周反应的负黏膜电位在 PD 患者和对照组之间没有差异,而 PD 患者的反应比 NPOD 患者更快,后者的反应比对照组更慢更大(18 PD,14 NPOD,20 C)。作为衡量三叉神经中枢反应的事件相关电位显示,与 NPOD 患者相比,PD 患者的早期成分反应更大(15 PD,21 NPOD,23 C)。如预期的那样,与对照组相比,两组患者的心理物理嗅觉测试均显示出嗅觉功能受损。判别分析显示,基于负黏膜电位潜伏期、嗅觉阈值和辨别测试,该模型可以预测 80%的参与者的组内成员。这些结果为 PD 患者三叉神经激活模式提供了新的见解,有助于将 PD 相关的嗅觉丧失与 NPOD 区分开来,这是为 PD 建立早期嗅觉筛查测试的重要一步,包括嗅觉测试。